Immunocore Holdings plc — Form D

Immunocore Holdings plc of Abingdon, Oxfordshire, X0, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-28. The offering totals $140.0M, of which $140.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2022-07-28
Form: D
Accession: 0001231919-22-000050
Industry: Biotechnology
Exemptions: 06b
Total offering: $140.0M
Amount sold: $140.0M
Investors: 8
Date of first sale: 2022-07-20
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-454089

Issuer

Name: Immunocore Holdings plc
CIK: 0001671927
Entity type: Corporation
Jurisdiction: UNITED KINGDOM
Incorporated: 2021
Address: 92 PARK DRIVE, Abingdon, Oxfordshire, X0, OX14 4RY
Phone: +44 1235 438600

Officers, directors & promoters (12)

Name	Role	Location
John Bell	Director	New South Wales, C3
Travis Coy	Director	South San Francisco, CA
Roy Herbst	Director	Abingdon, Oxfordshire, X0
Bahija Jallal	Director	Seattle, WA
Siddharth Kaul	Director	Abingdon, Oxfordshire, X0
Robert Perez	Director	Abingdon, Oxfordshire, X0
Kristine Peterson	Director	Abingdon, Oxfordshire, X0
Peter Ratcliffe	Director	Abingdon, Oxfordshire, X0
David Berman	Executive Officer	Birmingham, MI
Brian Di Donato	Executive Officer	Abingdon, Oxfordshire, X0
Bahija Jallal	Executive Officer	Seattle, WA
Tina St. Leger	Executive Officer	Abingdon, Oxfordshire, X0

More